Azd-1222/tozinameranGeneralised morphea: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1930卷 / 1期

关键词：

D O I：

10.1007/s40278-022-26386-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：123 / 123

相关论文

共 50 条

[21] AZD-1222/elasomeran/tozinameranAnaphylaxis: 5 case reports
Reactions Weekly, 2023, 1985 (1) : 107 - 107
[22] Azd-1222/tozinameranSubacute thyroiditis: 2 case reports
Reactions Weekly, 2022, 1912 (1) : 112 - 112
[23] AZD-1222/tozinameranImmune thrombocytopenia: 10 case reports
Reactions Weekly, 2022, 1902 (1) : 104 - 104
[24] AZD-1222/tozinameranOcular toxicities: 16 case reports
Reactions Weekly, 2023, 1941 (1) : 92 - 92
[25] Azd-1222/elasomeran/tozinameranLymphadenopathy: 7 case reports
Reactions Weekly, 2022, 1907 (1) : 102 - 102
[26] Azd-1222/tozinameranPemphigus foliaceus: 2 case reports
Reactions Weekly, 2022, 1935 (1) : 106 - 106
[27] Azd-1222/tozinameranSubacute thyroiditis: 2 case reports
Reactions Weekly, 2022, 1918 (1) : 95 - 95
[28] AZD-1222/elasomeran/tozinameranMyocarditis: 44 case reports
Reactions Weekly, 2023, 1977 (1) : 67 - 67
[29] Azd-1222/tozinameranVarious toxicities: 5 case reports
Reactions Weekly, 2022, 1917 (1) : 117 - 117
[30] Azd-1222/tozinameranAutoimmune myositis: 15 case reports
Reactions Weekly, 2023, 1952 (1) : 99 - 100

← 1 2 3 4 5 →